爱威品牌怎么样 申请店铺

我要投票 爱威在医疗器械行业中的票数:330 更新时间:2025-06-30
爱威是哪个国家的品牌?「爱威」是 爱威科技股份有限公司 旗下著名品牌。该品牌发源于湖南省长沙市,由创始人丁 * 文在2000年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力爱威品牌出海!将品牌入驻外推网,定制爱威品牌推广信息,可以显著提高爱威产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

爱威怎么样

爱威科技股份有限公司成立于2000年3月16日,总部位于湖南长沙高新技术产业开发区,是一家按照现代企业制度组建而成的专业从事医疗器械、实验仪器、体外诊断试剂与耗材、电子产品、远程医疗网络、计算机软件、自动控制设备、医疗辅助设备等产品的研究、开发、生产、销售及相关技术服务的现代企业。公司基于“创新驱动发展”战略,专注于临床医疗检验设备、体外诊断试剂及医用耗材的研发和产业化,自主创新研发的“医学显微镜形态学检验自动化”等多项关键共性技术处于国际出色地位。公司已成长为国内具国际竞争力的高性能医疗检验设备提供商,并于2015年2月在新三板挂牌上市(股票名称:爱威科技,股票代码:831895)。

爱威科技在国内外设立了两家全资子公司,其中湖南爱威医疗科技有限公司位于长沙岳麓区岳麓科技产业园,占地67亩,已建成高性能医疗器械及体外诊断试剂耗材研发与生产基地超过5万平方米;美国全资子公司AVETECH INC.(爱威科技(美国)有限公司)于2015年在美国马里兰州盖塞斯堡注册成立。

公司聚集了一批多学科领域的博士、硕士、本科等技术型人才,并承担了医学显微镜检验自动化湖南省工程研究中心等省部级工程研究中心的建设。公司专注于智能医学检验关键技术和相关医疗设备研发,尤其在自动显微镜形态学检验领域,形成了以国际前沿的“机器视觉技术”和“智能显微镜形态学检验技术”为核心的重大科技成果,实现了临床尿液、血液、粪便、体液等标本中有形病理成分显微图像高速可视,智能识别分类和定量计数,终结了显微镜检查只能依靠人工完成的历史。目前公司在全国30个省级行政区设立了办事机构,产品在国内装机用户已超过4000家;在国际上,产品已出口到欧洲、美洲、亚洲等国家和地区。

公司将继续秉承“科技服务健康”的核心理念,以“创造成果,实现价值,共同发展”为经营宗旨,通过自主研发和整合国际国内出色技术,采用专业的生产工艺,专注于医疗器械、实验仪器和体外诊断试剂、耗材等的研究、开发和产业化,使公司成长为国际、国内受人尊重的高性能医疗器械研发、制造和医疗健康服务行业的标杆企业,为实现“让老百姓都能享受现代医疗健康服务”的美好愿景而努力奋斗。


Founded on March 16, 2000 and headquartered in Changsha hi tech Industrial Development Zone, Hunan Province, AVIC Technology Co., Ltd. is a company established in accordance with the modern enterprise system, specializing in the research and development of medical devices, experimental instruments, in vitro diagnostic reagents and consumables, electronic products, telemedicine network, computer software, automatic control equipment, medical auxiliary equipment and other products A modern enterprise engaged in development, production, sales and related technical services. Based on the strategy of "innovation driven development", the company focuses on the R & D and industrialization of clinical medical testing equipment, in vitro diagnostic reagents and medical consumables, and many key generic technologies such as "medical microscope Morphology Test Automation" independently innovated and developed are in an outstanding position in the world. The company has grown into a high-performance medical inspection equipment provider with international competitiveness, and was listed on the new third board in February 2015 (Stock Name: AVIC technology, stock code: 831895). AVIC technology has set up two wholly-owned subsidiaries at home and abroad, of which Hunan AVIC Medical Technology Co., Ltd. is located in Yuelu science and Technology Industrial Park, Yuelu District, Changsha, covering an area of 67 mu, and has built a research and development and production base of high-performance medical devices and in vitro diagnostic reagent consumables of more than 50000 square meters; avetech Inc., a wholly-owned subsidiary of AVIC Technology (America) Co., Ltd., was in the United States in 2015 Gaicesburg, Maryland. The company has gathered a number of multi-disciplinary technical talents such as doctors, masters and undergraduates, and has undertaken the construction of provincial and ministerial engineering research centers such as Hunan Engineering Research Center of medical microscope inspection automation. The company focuses on the research and development of key technologies of intelligent medical examination and related medical equipment, especially in the field of automatic microscopic morphology examination. It has formed major scientific and technological achievements with the international cutting-edge "machine vision technology" and "intelligent microscopic morphology examination technology" as the core, realizing the high-speed microscopic image of tangible pathological components in clinical urine, blood, feces, body fluids and other specimens Visual, intelligent recognition, classification and quantitative counting have ended the history that microscopy can only be done by human. At present, the company has set up offices in 30 provincial administrative regions, with more than 4000 domestic installed users. Internationally, the products have been exported to Europe, America, Asia and other countries and regions. The company will continue to adhere to the core concept of "science and technology serve health", with the business purpose of "creating achievements, realizing value and common development", through independent research and development and integration of international and domestic excellent technology, adopting professional production technology, focusing on the research, development and industrialization of medical devices, experimental instruments, in vitro diagnostic reagents, consumables, etc., so that the company can grow into an international and national company The high-performance medical device R & D, manufacturing and medical and health service industry benchmarking enterprises that are respected by the people strive to realize the good vision of "let people enjoy modern medical and health services".

本文链接: https://brand.waitui.com/f8296e44c.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

海康威视:加拿大市场在公司2024年营业收入占比中不足0.3%

36氪获悉,海康威视在互动平台表示,加拿大市场在海康威视2024年营业收入占比中不足0.3%,面对各种政治打压,海康威视会继续努力服务好全球客户,继续为加拿大的客户提供产品和服务,会继续坚定推进国际化,会继续提升全球产品竞争力。

56分钟前

商业航天概念持续走高,博亚精工等多股涨停

36氪获悉,截至发稿,商业航天概念持续走高,博亚精工、凯美特气、利君股份、晨曦航空涨停,七丰精工、国科军工、爱乐达、星辰科技、豪能股份、中兵红箭等跟涨。

56分钟前

美国关税冲击下,日本5月工业产出环比仅增0.5%,远逊于预期

周一公布的政府数据显示,日本5月工业产出增速低于预期,因美国全面加征关税威胁到日本本已脆弱的经济复苏。日本经济产业省的数据显示,5月份工业产出环比增长0.5%,远低于3.5%的市场预期中值。日本经济产业省调查的制造商预计,经季节调整后的6月份工业产出将增长0.3%,7月份将下降0.7%。美国关税的打击可能会破坏日本疲弱的经济复苏。(新浪财经)

56分钟前

中信建投:下半年金价不排除会大幅回撤

36氪获悉,中信建投研报表示,1—4月金价大幅上涨至3500美元,核心是特朗普政策带来的不确定性。在下半年贸易缓和、复苏交易的判断下,黄金的短期利多不算明显,若叠加全球股市走强、俄乌冲突缓和等事件,风险偏好回升,在历史高位的金价不排除大幅回撤。

56分钟前

股票型基金新发规模创近四年同期新高

2025年行至年中,截至6月27日,年内已发行成立661只基金(按基金成立日计算),合计发行份额为5261亿份,平均发行份额为7.96亿份,创历史新低。债券基金发行情况不佳,拖累基金整体发行成绩,与之相反的是股票型基金新发规模则创出近四年同期新高。细分类型中,股票型基金有380只,合计发行份额为1855.32亿份,占新发权益基金的近八成;其新发数量、规模同比分别增长66.67%和179.24%,发行规模达到2022年以来同期新高。这主要得益于指数型基金的贡献:上半年成立366只指数基金,总发行份额为1832.03亿份,占据股票型基金新发规模的绝大部分。(中国基金报)

56分钟前

本页详细列出关于爱威的品牌信息,含品牌所属公司介绍,爱威所处行业的品牌地位及优势。
咨询